Join to View Full Profile
3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-418-4500
Fax+1 503-494-4473
Dr. Compadre is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Amanda Compadre, MD, is an Obstetrics and Gynecology specialist based in Saint Louis, MO. She completed her medical education at the University of Arkansas for Medical Sciences College of Medicine in 2018 and her residency in Obstetrics and Gynecology at the University of California, San Francisco, from 2018 to 2022. Dr. Compadre has contributed to several publications, addressing topics such as a toolkit for gynecologic oncology tissue banking, biomarkers in ovarian cancer, and case reports on ectopic pregnancy and pulmonary embolism in pregnancy. Her research has been cited multiple times, reflecting engagement with the academic community.
Education & Training
University of California (San Francisco)Residency, Obstetrics and Gynecology, 2018 - 2022
University of Arkansas For Medical Sciences College of MedicineClass of 2018
Certifications & Licensure
OR State Medical License 2025 - 2027
WA State Medical License 2025 - 2027
MO State Medical License 2022 - 2026
CA State Medical License 2019 - 2023
HI State Medical License 2020 - 2020
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- Developing patient-centered educational material to improve colposcopy adherence.Rida Qureshi, Naomi Peck, Amanda Compadre, Sarah Badwan, Yu Tao
Gynecologic Oncology Reports. 2026-04-01 - 2 citationsProvider insights to improve colposcopy adherence and feasibility of a social needs navigator program.Amanda J Compadre, Rachel Paul, Alexis Allihien, Rida Qureshi, Sarah Badwan
American Journal of Obstetrics and Gynecology. 2025-09-01 - 5 citationsPhospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.Angela Schab, Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez
The Journal of Clinical Investigation. 2025-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
